The DNAI1 gene helps build tiny hairlike structures called cilia, which move mucus out of the airways and help guide organ placement before birth. This gene plays an important role in keeping the nose, ears, and lungs clear. When it does not work properly, cilia may beat poorly and can cause primary ciliary dyskinesia, with ongoing sinus and chest infections, ear problems, and sometimes fertility issues. Some people also have organs arranged differently, such as the heart being on the right side.
What is a gene?
A gene is a piece of DNA that holds instructions your cells use to make molecules or regulate activities in the body. Some genes carry the directions for building proteins, which are the parts of cells that do much of the work. Others mainly guide when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medications. To look into this subject more closely, you can find more in the LearnHub.
Overview
DNAI1Gene function
What if the gene works
The DNAI1 gene helps build tiny hairlike structures called cilia on certain cells. These moving cilia help clear mucus from the airways and support sperm movement.
Risk
What if the gene does not work
Variants in the DNAI1 gene can cause primary ciliary dyskinesia, often with chronic sinus and lung problems. Some people also have organ placement differences or fertility issues. Milder and more severe variants can influence which features appear and how strongly.
Treatment
What does that mean for your treatment
No DNAI1-specific treatment or management approach is currently established. Care is guided by a person’s symptoms and routine measures used for primary ciliary dyskinesia, rather than by the DNAI1 gene itself. The DNAI1 gene is being studied in early gene-based treatment research, but this has not yet changed standard care.
Conditions associated with DNAI1
Gene function
What if the gene works
Inside certain cells, the DNAI1 gene helps build the moving parts of motile cilia, the tiny hair-like structures that sweep fluid across surfaces. When this gene is working normally, cilia can beat in a smooth, repeated pattern. This steady motion supports everyday tasks such as moving mucus in the airways and fluids in other parts of the body.
The DNAI1 gene helps form part of the protein motor that drives each cilia beat. This motor gives motile cilia the force needed to bend and return in a steady rhythm.
Inside your cells, this gene helps organize the outer dynein arm, a key motor unit on motile cilia. Proper DNAI1 gene function supports stable placement of these motors along the cilia surface.
By powering cilia motion, the DNAI1 gene supports the movement of mucus and other fluids along body surfaces. This allows cells to create a directed flow that helps keep those surfaces working smoothly.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variations in appearance, metabolism, and the way the body reacts to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the DNAI1 gene can change the shape, stability, or assembly of a protein that helps build the tiny motors that move cilia. In practical terms, how DNAI1 gene variants affect cilia movement depends on the change: some milder variants leave partial activity, while more disruptive variants can greatly reduce or stop protein production. This often weakens cilia beating at the cellular level. In primary ciliary dyskinesia, stronger loss of function may contribute to earlier or more consistent symptoms.
How variants are linked to conditions
Pathogenic variants in the DNAI1 gene cause primary ciliary dyskinesia, a condition linked to ongoing chest infections, chronic nasal congestion, ear problems, and sometimes fertility issues. Some people with DNAI1 gene related primary ciliary dyskinesia also have organs arranged in a mirror image pattern, called situs inversus.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply reflect natural human diversity. For many genes, a variant connected with a condition points to a possible association, not a definite diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For DNAI1, risk is mainly shaped by inheritance: primary ciliary dyskinesia usually happens when a child inherits a nonworking copy from both parents. There is not broadly confirmed evidence that lifestyle or everyday exposures meaningfully change whether someone with DNAI1 variants will have the condition.
Inheritance of DNAI1 variants
Variants in the DNAI1 gene are usually inherited in an autosomal recessive pattern, which means a person needs to inherit two changed copies, one from each parent, to have a DNAI1-related condition such as primary ciliary dyskinesia. Parents who each carry one variant usually do not have the condition themselves. When both parents are carriers, each pregnancy has a 25% chance of being affected, a 50% chance of resulting in a child who is a carrier, and a 25% chance of inheriting neither variant.
What does my DNAI1 result mean for my family?
For DNAI1, family members are most often affected in a recessive pattern. This usually means parents can be healthy carriers, and brothers or sisters may also be carriers or, more rarely, have the same condition. Other relatives may want to know there could be a shared family variant, especially if there is a history of long-term sinus, ear, chest, or fertility problems.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for the DNAI1 gene usually uses a blood or saliva sample to read the gene’s DNA and look for variants. DNAI1 genetic testing can help confirm whether a known variant is present and may clarify if your results fit an inherited condition. Results are reviewed in a lab and grouped as benign, uncertain, or disease causing.
When should I consider getting a genetic test?
Consider DNAI1 testing if you or your child has signs of primary ciliary dyskinesia, a condition where tiny airway cleaners do not work well. Clues include a daily wet cough from early life, repeated sinus, ear, or chest infections, fertility problems, or organs developing on the opposite side.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, yet how much it can tell you depends on the condition and the kind of variant involved. How the body functions over time is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small inherited differences can change how the body breaks down a drug, moves it through the body, or responds to it at its target. Because of this, the same medication may work better for some people, work less well for others, or cause more side effects in some individuals.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies gene and drug patterns to help explain why the same treatment can work differently from one person to another. For many drugs, genes influence how strongly a medication works or how the body handles it. This information can support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the DNAI1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how people respond to medicines, so any questions about symptoms, side effects, or treatment changes are best discussed with your doctor.
History
Doctors had described the combination of long term chest infections, sinus problems, and reversed organ placement for decades before the genetic cause became clearer. Inheritance patterns were noticed long before the gene was identified. A major step came in 1999, when researchers linked variants in the DNAI1 gene to primary ciliary dyskinesia, including some families with Kartagener syndrome. This was one of the first clear genetic findings for the condition and helped move the field from describing symptoms to tracing inherited causes. From these first observations, research expanded steadily, and the DNAI1 gene became an important early chapter in understanding this group of conditions. That work also opened the way for broader genetic testing and more precise classification.